134 related articles for article (PubMed ID: 30823949)
1. Differential Expression of Placental Growth Factor, Transforming Growth Factor-β and Soluble Endoglin in Peripheral Mononuclear Cells in Preeclampsia.
Ali Z; Ali Z; Khaliq S; Zaki S; Ahmad HU; Lone KP
J Coll Physicians Surg Pak; 2019 Mar; 29(3):235-239. PubMed ID: 30823949
[TBL] [Abstract][Full Text] [Related]
2. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
3. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
[TBL] [Abstract][Full Text] [Related]
4. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
5. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
[TBL] [Abstract][Full Text] [Related]
7. Elevated Tumor Necrosis Factor (TNF)-α mRNA Expression Correlates with Nuclear Factor Kappa B Expression in Peripheral Blood Mononuclear Cells in Preeclampsia.
Ali Z; Zafar U; Khaliq S; Lone KP
J Coll Physicians Surg Pak; 2020 Feb; 30(2):158-162. PubMed ID: 32036823
[TBL] [Abstract][Full Text] [Related]
8. Association between endoglin/transforming growth factor beta receptors 1, 2 gene polymorphisms and the level of soluble endoglin with preeclampsia in Egyptian women.
ElMonier AA; El-Boghdady NA; Abdelaziz MA; Shaheen AA
Arch Biochem Biophys; 2019 Feb; 662():7-14. PubMed ID: 30496724
[TBL] [Abstract][Full Text] [Related]
9. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset.
Hirashima C; Ohkuchi A; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Res; 2008 Aug; 31(8):1541-8. PubMed ID: 18971528
[TBL] [Abstract][Full Text] [Related]
10. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
Lim JH; Kim SY; Park SY; Lee MH; Yang JH; Kim MY; Chung JH; Lee SW; Ryu HM
Prenat Diagn; 2009 May; 29(5):471-6. PubMed ID: 19253312
[TBL] [Abstract][Full Text] [Related]
11. Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia.
Rădulescu C; Bacârea A; Huțanu A; Gabor R; Dobreanu M
Mediators Inflamm; 2016; 2016():3027363. PubMed ID: 27799724
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
[TBL] [Abstract][Full Text] [Related]
13. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
[TBL] [Abstract][Full Text] [Related]
14. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
15. Modification of angiogenic factors by regular and acute exercise during pregnancy.
Weissgerber TL; Davies GA; Roberts JM
J Appl Physiol (1985); 2010 May; 108(5):1217-23. PubMed ID: 20224004
[TBL] [Abstract][Full Text] [Related]
16. Multiple Soluble TGF-β Receptors in Addition to Soluble Endoglin Are Elevated in Preeclamptic Serum and They Synergistically Inhibit TGF-β Signaling.
Wang Y; Chen Q; Zhao M; Walton K; Harrison C; Nie G
J Clin Endocrinol Metab; 2017 Aug; 102(8):3065-3074. PubMed ID: 28633389
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of TGF-β1, cytokines, angiogenic, and anti-angiogenic factors in pregnant women who smoke.
Schubert CL; Yusuf K
J Reprod Immunol; 2021 Sep; 147():103351. PubMed ID: 34293588
[TBL] [Abstract][Full Text] [Related]
18. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
[TBL] [Abstract][Full Text] [Related]
19. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
[TBL] [Abstract][Full Text] [Related]
20. Peripheral arterial tonometry and angiogenic biomarkers in preeclampsia.
Kumer K; Premru-Sršen T; Fabjan-Vodušek V; Tul N; Fabjan T; Osredkar J
Hypertens Pregnancy; 2018 Nov; 37(4):197-203. PubMed ID: 30282501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
